Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice

European Neuropsychopharmacology

Volumn 15, Issue 1, 2005, Pages 57-67

  Kurosaki, Rumiko ^a,b   Muramatsu, Yasuko ^a   Kato, Hiroyuki ^c   Watanabe, Yu ^b   Imai, Yutaka ^a   Itoyama, Yasuto ^c   Araki, Tsutomu ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic system; Immunohistochemistry; Mice; Neuronal nitric oxide synthase; Parvalbumin; Perindopril

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; HOMOVANILLIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN; PERINDOPRIL; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TIME;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROCHEMISTRY; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PARVALBUMINS; PERINDOPRIL; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 9644289588     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.05.007     Document Type: Article

References (51)

1. Araki T., Kato H., Liu X.H., Kogure K., Kato K., Itoyama Y. An immunohistochemical study of parvalbumin containing interneurons in gerbil hippocampus after cerebral ischemia. Metab. Brain Dis. 9:1994;225-234
2. Araki T., Kumagai T., Tanaka K., Matsubara M., Kato H., Itoyama Y., Imai Y. Neuroprotective effect of riluzole in MPTP-treated mice. Brain Res. 918:2001;176-181
3. Araki T., Mikami T., Tanji H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Biochemical and immunohistochemical changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Eur. J. Pharm. Sci. 12:2001;231-238
4. Arregui A., Bennett J.P. Jr., Bird E.D., Yamamura H.I., Iversen L.L., Snyder S.H. Huntington's chorea: selective depletion of activity of angiotensin converting enzyme in the corpus striatum. Ann. Neurol. 2:1977;294-298
5. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624
6. Beckman J.S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J., Harrison J., Martin J.C., Tsai M. Kinetics of superoxide dismutase-and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:1992;438-445
7. Betarbet R., Turner R., Chockkan V., DeLong M.R., Allers K.A., Walters J., Levey A.L., Greenamye T. Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17:1997;6761-6768
8. Bieganowaka K., Czlonkowska A., Bidzinski A., Mierzewska H., Korlak J. Immunological changes in the MPTP-induced Parkinson's disease mouse model. J. Neuroimmunol. 42:1993;33-37
9. Bredt D.S., Clatt C.E., Huang P.L., Fotuhi M., Dawson T.M., Snyder S.H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mechanisms CNS together with NADPH diaphorase. Neuron. 7:1991;615-624
10. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685
11. Celio M.R. Parvalbumin in most γ-aminobutyric acid-containing neurons of the rat cerebral cortex. Science. 231:1986;995-997
12. Celio M.R. Calbindin D-28 k and parvalbumin in the rat nervous system. Neuroscience. 35:1990;375-475
13. Chai S.Y., Paxinos G., Mendelsolhn F.A.O. Angiotensin converting enzyme in rat brain visualized by in vivo autoradiography. Neuroscience. 20:1987;615-627
14. Croog S.H., Levins S., Testa M.A., Brown B., Bulpritt C.J., Jenkins C.D., Klerman G.L., Williams G.H. The effects of antihypertensive therapy on the quality of life. New Engl. J. Med. 314:1986;1657-1664
15. Dahlof B., Pennerk K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am. J. Hypertens. 5:1992;95-110
16. Dawson V.L., Dawson T.D., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediate glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371
17. Dawson T.M., Snyder S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5149
18. Dinerman I.L., Dawson T.M., Schell M.I., Snowman A., Snyder S.H. Endotherial nitric oxide synthase localization to hippocampal pyramidal cells: implications for synaptic placidity. Proc. Natl. Acad. Sci. USA. 91:1994;4214-4218
19. Ferer I., Kulisevsky J., Gonzalez G., Escartin A., Chivite A., Casas R. Parvalbumin-immunoreactive neurons in the cerebral cortex in Huntington's disease. Brain Res. 411:1994;162-166
20. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereo Taxic Coordinates. 1997;Academic Press, San Diego
21. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 9:1996;1017-1021
22. Hardman C.D., McRitchie D.A., Halliday G.M., Cartwright H.R., Morris L.G.L. Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration. 5:1996;49-55
23. Harrington K.M., Kowall. Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J. Neuropathol. Exp. Neurol. 50:1991;309
24. Hasegawa E., Takeshige K., Oishi T., Murai Y., Minakami S. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170:1990;1049-1055
25. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fischman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1275-1285
26. Iadecola C., Xu X., Zhang F., el-Fakahany E.E., Ross M.E. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;52-59
27. Jenkins T.A., Mendelsohn F.O.A., Chai S.Y. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J. Neurochem. 68:1997;1304-1311
28. Jenkins T.A., Wong J.Y.F., Howells D.W., Mendelsohn F.A.O., Chai S.Y. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mice. J. Neurochem. 73:1999;214-219
29. Kato H., Kogure K., Araki T., Liu T.X., Kato K., Itoyama Y. Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance. J. Cereb. Blood Flow Metab. 15:1995;60-70
30. Kurkowska-Jastrzebska I., Wroñska A., Kohutnicka M., Czlonkowski A., Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 156:1999;50-61
31. Kurosaki R., Muramatsu Y., Michimata M., Matsubara M., Kato H., Imai Y., Itoyama Y., Araki T. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol. Res. 24:2002;655-662
32. Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA. 89:1992;6711-6715
33. Marletta M.A. Nitric oxide synthase structure and mechanisms. J. Biol. Chem. 268:1993;12331-12334
34. Moncada S., Palmer P.M.J., Higges E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142
35. Muramatsu Y., Kurosaki R., Mikami T., Michimata M., Matsubara M., Imai Y., Kato H., Itoyama Y., Araki T. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice. Metab. Brain Dis. 17:2002;169-182
36. ·OH generation in rat striatum. Eur. J. Pharmacol. 378:1999;39-45
37. Onodera T., Okazaki F., Miyazaki H., Minami S., Ito T., Seki S., Taniguchi M., Taniguchi I., Mochizuki S. Perindopril reverses myocyte remodeling in the hypertensive heart. Hypertens. Res. 25:2002;85-90
38. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.D. Role of neuronal nitric oxide in MPTP (1-methyl-1,2,3,6- tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571
39. Reardon K.A., Chai S.Y., Mcndclsohn F.A.O., Horne M.K. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust. New Zeland J. Med. 30:2000;48-53
40. Ricaurte G.A., Irwin I., Forno L.S., Delanney E., Langston E., Langston J.W. Ageing and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403:1987;43-51
41. Sadoshima J., Izumo S. Molecular characterization of angiotensin II Induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the ATI receptor subtype. Circ. Res. 73:1993;413-423
42. Sakaguchi K., Chai S.Y., Jackson B., Johnston C.I., Mendelsohn F.A.O. Differential angiotensin converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography. Neuroendocrinology. 48:1988;223-238
43. Savaskan E., Hock C., Olivieri G., Bruttel S., Rosenberg C., Hulette C., Müller-Spahn F. Cortical alterations of angiotensin converting enzyme, angiotensin II and ATI receptors in Alzheimer's dementia. Neurobiol. Aging. 22:2001;541-546
44. Schultz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase 7-nitroindazole protects against MPTP- induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939
45. Simmons M.L., Murphy S. Induction of nitric oxide synthase in glia cells. J. Neurochem. 59:1992;936-939
46. Sriram K., Pai K.S., Boyd M.R., Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res. 749:1997;44-52
47. Tanji T., Araki T., Nagasawa H., Itoyama Y. Differential vulnerability of dopaminergic receptors in the mouse brain treated by MPTP. Brain Res. 824:1999;224-231
48. Tipton K.F., Singer T.P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206
49. van der Vliet A., O'Neill C.A., Halliwell B., Cross C.E., Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxy radical production from peroxynitite. FEBS Lett. 399:1994;89-92
50. Zubenko G.S., Nixon R.A. Mood-elevating effect of captopril in depressed patients. Am. J. Psychiatry. 141:1984;110-111
51. Zubenko G.S., Volicer L., Direnfeld L.K., Freeman M., Langlais P.J., Nixon R.A. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. Brain Res. 328:1985;215-221